Monopar Therapeutics Form 4 insider transactions

Kim R. Tsuchimoto, CFO of Monopar Therapeutics, reports the vesting and settlement of restricted stock units resulting in the acquisition and disposal of common stock.

Chandler Robinson, CEO of Monopar Therapeutics, reports the acquisition and disposal of common stock and restricted stock units related to vesting.